Exclusive

Publication

Byline

कन्या पूजन कर लिया आशीर्वाद

मेरठ, मार्च 26 -- गुरुवार को अष्टमी और नवमी के पावन अवसर पर सरधना क्षेत्र में भक्तिभाव और आस्था का अनूठा संगम देखने को मिला। श्रद्धालुओं ने विधि-विधान से पूजा-अर्चना कर भगवान श्रीराम का जन्मोत्सव मनाय... Read More


हमला करने पर मुकदमा दर्ज

उरई, मार्च 26 -- कालपी। स्थानीय कोतवाली क्षेत्र के एक ग्राम में अपने घर के बाहर बैठे पिता पुत्र व पुत्री पर हमला करने के मामले में पीड़ित के द्वारा नामजद आरोपी के खिलाफ पुलिस में सुसंगत धाराओं में मुक... Read More


बालिका को बहला फुसलाकर ले गए

फर्रुखाबाद कन्नौज, मार्च 26 -- मोहम्मदाबाद। एक गांव की दलित बालिका को कुछ लोग बहला फुसलाकर ले गये। इसको लेकर पुलिस मे रिपोर्ट दर्ज कराने को तहरीर दी गयी है। एक महिला ने पुलिस को दिये गये प्रार्थना पत्... Read More


दबंग ने पति-पत्नी को पीटा, धमकाया

बांदा, मार्च 26 -- बांदा। संवाददाता देहात कोतवाली के छनेहरा लालपुर गांव निवासी रहमत उल्ला ने मारपीट की रिपोर्ट दर्ज कराई है। आरोप लगाया कि मंगलवार को शाम पांच बजे गांव के मदला पुत्र हबीब ने उसके साथ म... Read More


23 dead in Bangladesh as bus falls into river while trying to hop on ferry

India, March 26 -- At least 23 people died in Bangladesh's Rajbari district on Wednesday after a bus plunged into a river, reportedly while trying to get onto a transport ferry. A rescue and search op... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More


Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... Read More


Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... Read More


Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... Read More